Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 15, 2012 10:35 ET | Source: Aeolus Pharmaceuticals

Aeolus Announces No-Cost Extension and Modification of Barda Contract Fully Valued at $118 Million to Develop Treatment for Lung Acute Radiation Syndrome

MISSION VIEJO, CA--(Marketwire - Feb 15, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS) Restructure driven by additional items added to base...
February 13, 2012 17:40 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2012 Financial Results

MISSION VIEJO, CA--(Marketwire - Feb 13, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS) $2.2 million in revenue Meeting to request...
February 08, 2012 14:35 ET | Source: Aeolus Pharmaceuticals

Aeolus' AEOL 10150 Protects Lung Tissue From Radiation by Modulating PTEN Levels, Reducing Oxidative Stress and Apoptosis

MISSION VIEJO, CA--(Marketwire - Feb 8, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS) Data published in the International Journal of Radiation...
February 07, 2012 06:00 ET | Source: Aeolus Pharmaceuticals

Positive Data on AEOL 11207 in Pre-Clinical Epilepsy Model Published in the Journal of Neurobiology of Disease

MISSION VIEJO, CA--(Marketwire - Feb 7, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a...
January 17, 2012 06:58 ET | Source: Aeolus Pharmaceuticals

Aeolus to Present at the Noble Financial Capital Markets' 8th Annual Equity Conference

MISSION VIEJO, CA--(Marketwire - Jan 17, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a...
December 27, 2011 19:10 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals Announces Fiscal Year 2011 Results

MISSION VIEJO, CA--(Marketwire - Dec 27, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a...
December 07, 2011 11:17 ET | Source: Aeolus Pharmaceuticals

Aeolus to Present at the 22nd Annual Oppenheimer Healthcare Conference

MISSION VIEJO, CA--(Marketwire - Dec 7, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a...
November 09, 2011 09:05 ET | Source: Aeolus Pharmaceuticals

Aeolus to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

MISSION VIEJO, CA--(Marketwire - Nov 9, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a platform...
November 01, 2011 08:00 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals Announces Positive Results From Study of AEOL 10150 and Neupogen(R) as Combination Therapy for Treatment of Acute Radiation Syndrome

MISSION VIEJO, CA--(Marketwire - Nov 1, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a...
October 24, 2011 10:02 ET | Source: Aeolus Pharmaceuticals

Aeolus to Present at the 10th Annual BIO Investor Forum

MISSION VIEJO, CA--(Marketwire - Oct 24, 2011) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant funding from the U.S. Department of...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right